This invention relates to derivatives of 3,6-disubstituted azabicyclo
hexanes. The compounds of this invention can function as muscarinic
receptor antagonists and can be used for the treatment of various
diseases of the respiratory, urinary and gastrointestinal systems
mediated through muscarinic receptors.